Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 3 up days in a row

<According to Leckrone at the SHM, we are not in very good shape on the '584>

I think the above statement puts a more negative spin than what you originally said. Which was-

<He responded by admitting that we were currently not in a very good position regarding claim 29 on the “584 patent, no surprise there. >

IMO No surprise because we lost the appeal. That put the patent in a weakend position. Currently because we do not know what the patent is going to look like when it exits the USPTO review. It was modified. If Leckrone acutally used the term currently, it might suggest that our position might improve? Opty

Share
New Message
Please login to post a reply